CASI Pharmaceuticals
CASI
#8912
Rank
NZ$0.14 B
Marketcap
$9.08
Share price
-3.96%
Change (1 day)
21.24%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -NZ$44.27 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are NZ$23.1 Million. In 2023 the company made an earning of -NZ$44.96 Million, an increase over its 2022 earnings that were of -NZ$63.81 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$44.27 Million-1.52%
2023 -NZ$44.96 Million-29.55%
2022 -NZ$63.81 Million4.43%
2021 -NZ$61.1 Million-24.56%
2020 -NZ$80.99 Million4.74%
2019 -NZ$77.32 Million65.13%
2018 -NZ$46.83 Million155.07%
2017 -NZ$18.36 Million13.93%
2016 -NZ$16.12 Million31.18%
2015 -NZ$12.29 Million-72.5%
2014 -NZ$44.67 Million356.62%
2013 -NZ$9.79 Million-60.55%
2012 -NZ$24.8 Million218.41%
2011 -NZ$7.79 Million0.74%
2010 -NZ$7.73 Million-32.54%
2009 -NZ$11.46 Million-66.98%
2008 -NZ$34.7 Million-14.22%
2007 -NZ$40.45 Million7.04%
2006 -NZ$37.79 Million27.95%
2005 -NZ$29.54 Million4.51%
2004 -NZ$28.27 Million-15.84%
2003 -NZ$33.58 Million-55.29%
2002 -NZ$75.11 Million-34.05%
2001 -NZ$0.12 Billion31.73%
2000 -NZ$86.45 Million31.56%
1999 -NZ$65.72 Million145.56%
1998 -NZ$26.77 Million76.4%
1997 -NZ$15.18 Million36.92%
1996 -NZ$11.08 Million